 | • レポートコード：MRC2-11QY03955 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は神経調節のグローバル市場について調査・分析したレポートです。種類別（脳深部刺激療法、脊髄刺激療法、経頭蓋磁気刺激療法）市場規模、用途別（病院＆クリニック、外来手術センター（ASC））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別神経調節の競争状況、市場シェア ・世界の神経調節市場：種類別市場規模 2015年-2020年（脳深部刺激療法、脊髄刺激療法、経頭蓋磁気刺激療法） ・世界の神経調節市場：種類別市場規模予測 2021年-2026年（脳深部刺激療法、脊髄刺激療法、経頭蓋磁気刺激療法） ・世界の神経調節市場：用途別市場規模 2015年-2020年（病院＆クリニック、外来手術センター（ASC）） ・世界の神経調節市場：用途別市場規模予測 2021年-2026年（病院＆クリニック、外来手術センター（ASC）） ・北米の神経調節市場分析：米国、カナダ ・ヨーロッパの神経調節市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの神経調節市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の神経調節市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの神経調節市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Medtronic、Boston Scientific、Jude Medical、Synapse Biomedical、Nevro、Neurosigma、Neuropace、Neuronetics、Cyberonics、BioControl Medical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons.
The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer’s and Parkinson’s diseases, and the increase in awareness regarding the safety and efficacy of neurostimulator devices. However, restrains, such as lack of trained healthcare professionals and stringent approval policies, are expected to hinder the market.
Market Analysis and Insights: Global Neuromodulation Market
The global Neuromodulation market size is projected to reach US$ 2374.3 million by 2026, from US$ 2161.3 million in 2020, at a CAGR of 9.0%% during 2021-2026.
Global Neuromodulation Scope and Market Size
Neuromodulation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuromodulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Medtronic
Boston Scientific
Jude Medical
Synapse Biomedical
Nevro
Neurosigma
Neuropace
Neuronetics
Cyberonics
BioControl Medical
Market segment by Type, the product can be split into
Deep Brain Stimulation
Spinal Cord Stimulation
Transcranial Magnetic Stimulation
Market segment by Application, split into
Hospitals & Clinics
Ambulatory Surgery Centers (ASCs)
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neuromodulation Revenue
1.4 Market by Type
1.4.1 Global Neuromodulation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Deep Brain Stimulation
1.4.3 Spinal Cord Stimulation
1.4.4 Transcranial Magnetic Stimulation
1.5 Market by Application
1.5.1 Global Neuromodulation Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Ambulatory Surgery Centers (ASCs)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Neuromodulation Market Perspective (2015-2026)
2.2 Global Neuromodulation Growth Trends by Regions
2.2.1 Neuromodulation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neuromodulation Historic Market Share by Regions (2015-2020)
2.2.3 Neuromodulation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Neuromodulation Market Growth Strategy
2.3.6 Primary Interviews with Key Neuromodulation Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Neuromodulation Players by Market Size
3.1.1 Global Top Neuromodulation Players by Revenue (2015-2020)
3.1.2 Global Neuromodulation Revenue Market Share by Players (2015-2020)
3.1.3 Global Neuromodulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neuromodulation Market Concentration Ratio
3.2.1 Global Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Neuromodulation Revenue in 2019
3.3 Neuromodulation Key Players Head office and Area Served
3.4 Key Players Neuromodulation Product Solution and Service
3.5 Date of Enter into Neuromodulation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Neuromodulation Historic Market Size by Type (2015-2020)
4.2 Global Neuromodulation Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Neuromodulation Market Size by Application (2015-2020)
5.2 Global Neuromodulation Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Neuromodulation Market Size (2015-2020)
6.2 Neuromodulation Key Players in North America (2019-2020)
6.3 North America Neuromodulation Market Size by Type (2015-2020)
6.4 North America Neuromodulation Market Size by Application (2015-2020)
7 Europe
7.1 Europe Neuromodulation Market Size (2015-2020)
7.2 Neuromodulation Key Players in Europe (2019-2020)
7.3 Europe Neuromodulation Market Size by Type (2015-2020)
7.4 Europe Neuromodulation Market Size by Application (2015-2020)
8 China
8.1 China Neuromodulation Market Size (2015-2020)
8.2 Neuromodulation Key Players in China (2019-2020)
8.3 China Neuromodulation Market Size by Type (2015-2020)
8.4 China Neuromodulation Market Size by Application (2015-2020)
9 Japan
9.1 Japan Neuromodulation Market Size (2015-2020)
9.2 Neuromodulation Key Players in Japan (2019-2020)
9.3 Japan Neuromodulation Market Size by Type (2015-2020)
9.4 Japan Neuromodulation Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Neuromodulation Market Size (2015-2020)
10.2 Neuromodulation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neuromodulation Market Size by Type (2015-2020)
10.4 Southeast Asia Neuromodulation Market Size by Application (2015-2020)
11 India
11.1 India Neuromodulation Market Size (2015-2020)
11.2 Neuromodulation Key Players in India (2019-2020)
11.3 India Neuromodulation Market Size by Type (2015-2020)
11.4 India Neuromodulation Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Neuromodulation Market Size (2015-2020)
12.2 Neuromodulation Key Players in Central & South America (2019-2020)
12.3 Central & South America Neuromodulation Market Size by Type (2015-2020)
12.4 Central & South America Neuromodulation Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview
13.1.3 Medtronic Neuromodulation Introduction
13.1.4 Medtronic Revenue in Neuromodulation Business (2015-2020))
13.1.5 Medtronic Recent Development
13.2 Boston Scientific
13.2.1 Boston Scientific Company Details
13.2.2 Boston Scientific Business Overview
13.2.3 Boston Scientific Neuromodulation Introduction
13.2.4 Boston Scientific Revenue in Neuromodulation Business (2015-2020)
13.2.5 Boston Scientific Recent Development
13.3 Jude Medical
13.3.1 Jude Medical Company Details
13.3.2 Jude Medical Business Overview
13.3.3 Jude Medical Neuromodulation Introduction
13.3.4 Jude Medical Revenue in Neuromodulation Business (2015-2020)
13.3.5 Jude Medical Recent Development
13.4 Synapse Biomedical
13.4.1 Synapse Biomedical Company Details
13.4.2 Synapse Biomedical Business Overview
13.4.3 Synapse Biomedical Neuromodulation Introduction
13.4.4 Synapse Biomedical Revenue in Neuromodulation Business (2015-2020)
13.4.5 Synapse Biomedical Recent Development
13.5 Nevro
13.5.1 Nevro Company Details
13.5.2 Nevro Business Overview
13.5.3 Nevro Neuromodulation Introduction
13.5.4 Nevro Revenue in Neuromodulation Business (2015-2020)
13.5.5 Nevro Recent Development
13.6 Neurosigma
13.6.1 Neurosigma Company Details
13.6.2 Neurosigma Business Overview
13.6.3 Neurosigma Neuromodulation Introduction
13.6.4 Neurosigma Revenue in Neuromodulation Business (2015-2020)
13.6.5 Neurosigma Recent Development
13.7 Neuropace
13.7.1 Neuropace Company Details
13.7.2 Neuropace Business Overview
13.7.3 Neuropace Neuromodulation Introduction
13.7.4 Neuropace Revenue in Neuromodulation Business (2015-2020)
13.7.5 Neuropace Recent Development
13.8 Neuronetics
13.8.1 Neuronetics Company Details
13.8.2 Neuronetics Business Overview
13.8.3 Neuronetics Neuromodulation Introduction
13.8.4 Neuronetics Revenue in Neuromodulation Business (2015-2020)
13.8.5 Neuronetics Recent Development
13.9 Cyberonics
13.9.1 Cyberonics Company Details
13.9.2 Cyberonics Business Overview
13.9.3 Cyberonics Neuromodulation Introduction
13.9.4 Cyberonics Revenue in Neuromodulation Business (2015-2020)
13.9.5 Cyberonics Recent Development
13.10 BioControl Medical
13.10.1 BioControl Medical Company Details
13.10.2 BioControl Medical Business Overview
13.10.3 BioControl Medical Neuromodulation Introduction
13.10.4 BioControl Medical Revenue in Neuromodulation Business (2015-2020)
13.10.5 BioControl Medical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Neuromodulation Key Market Segments
Table 2. Key Players Covered: Ranking by Neuromodulation Revenue
Table 3. Ranking of Global Top Neuromodulation Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neuromodulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Deep Brain Stimulation
Table 6. Key Players of Spinal Cord Stimulation
Table 7. Key Players of Transcranial Magnetic Stimulation
Table 8. Global Neuromodulation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Neuromodulation Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Neuromodulation Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Neuromodulation Market Share by Regions (2015-2020)
Table 12. Global Neuromodulation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Neuromodulation Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Neuromodulation Market Growth Strategy
Table 18. Main Points Interviewed from Key Neuromodulation Players
Table 19. Global Neuromodulation Revenue by Players (2015-2020) (Million US$)
Table 20. Global Neuromodulation Market Share by Players (2015-2020)
Table 21. Global Top Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulation as of 2019)
Table 22. Global Neuromodulation by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neuromodulation Product Solution and Service
Table 25. Date of Enter into Neuromodulation Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 28. Global Neuromodulation Market Size Share by Type (2015-2020)
Table 29. Global Neuromodulation Revenue Market Share by Type (2021-2026)
Table 30. Global Neuromodulation Market Size Share by Application (2015-2020)
Table 31. Global Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 32. Global Neuromodulation Market Size Share by Application (2021-2026)
Table 33. North America Key Players Neuromodulation Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Neuromodulation Market Share (2019-2020)
Table 35. North America Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 36. North America Neuromodulation Market Share by Type (2015-2020)
Table 37. North America Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 38. North America Neuromodulation Market Share by Application (2015-2020)
Table 39. Europe Key Players Neuromodulation Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Neuromodulation Market Share (2019-2020)
Table 41. Europe Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Neuromodulation Market Share by Type (2015-2020)
Table 43. Europe Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Neuromodulation Market Share by Application (2015-2020)
Table 45. China Key Players Neuromodulation Revenue (2019-2020) (Million US$)
Table 46. China Key Players Neuromodulation Market Share (2019-2020)
Table 47. China Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 48. China Neuromodulation Market Share by Type (2015-2020)
Table 49. China Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 50. China Neuromodulation Market Share by Application (2015-2020)
Table 51. Japan Key Players Neuromodulation Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Neuromodulation Market Share (2019-2020)
Table 53. Japan Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Neuromodulation Market Share by Type (2015-2020)
Table 55. Japan Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Neuromodulation Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Neuromodulation Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Neuromodulation Market Share (2019-2020)
Table 59. Southeast Asia Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Neuromodulation Market Share by Type (2015-2020)
Table 61. Southeast Asia Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Neuromodulation Market Share by Application (2015-2020)
Table 63. India Key Players Neuromodulation Revenue (2019-2020) (Million US$)
Table 64. India Key Players Neuromodulation Market Share (2019-2020)
Table 65. India Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 66. India Neuromodulation Market Share by Type (2015-2020)
Table 67. India Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 68. India Neuromodulation Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Neuromodulation Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Neuromodulation Market Share (2019-2020)
Table 71. Central & South America Neuromodulation Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Neuromodulation Market Share by Type (2015-2020)
Table 73. Central & South America Neuromodulation Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Neuromodulation Market Share by Application (2015-2020)
Table 75. Medtronic Company Details
Table 76. Medtronic Business Overview
Table 77. Medtronic Product
Table 78. Medtronic Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 79. Medtronic Recent Development
Table 80. Boston Scientific Company Details
Table 81. Boston Scientific Business Overview
Table 82. Boston Scientific Product
Table 83. Boston Scientific Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 84. Boston Scientific Recent Development
Table 85. Jude Medical Company Details
Table 86. Jude Medical Business Overview
Table 87. Jude Medical Product
Table 88. Jude Medical Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 89. Jude Medical Recent Development
Table 90. Synapse Biomedical Company Details
Table 91. Synapse Biomedical Business Overview
Table 92. Synapse Biomedical Product
Table 93. Synapse Biomedical Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 94. Synapse Biomedical Recent Development
Table 95. Nevro Company Details
Table 96. Nevro Business Overview
Table 97. Nevro Product
Table 98. Nevro Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 99. Nevro Recent Development
Table 100. Neurosigma Company Details
Table 101. Neurosigma Business Overview
Table 102. Neurosigma Product
Table 103. Neurosigma Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 104. Neurosigma Recent Development
Table 105. Neuropace Company Details
Table 106. Neuropace Business Overview
Table 107. Neuropace Product
Table 108. Neuropace Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 109. Neuropace Recent Development
Table 110. Neuronetics Business Overview
Table 111. Neuronetics Product
Table 112. Neuronetics Company Details
Table 113. Neuronetics Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 114. Neuronetics Recent Development
Table 115. Cyberonics Company Details
Table 116. Cyberonics Business Overview
Table 117. Cyberonics Product
Table 118. Cyberonics Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 119. Cyberonics Recent Development
Table 120. BioControl Medical Company Details
Table 121. BioControl Medical Business Overview
Table 122. BioControl Medical Product
Table 123. BioControl Medical Revenue in Neuromodulation Business (2015-2020) (Million US$)
Table 124. BioControl Medical Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuromodulation Market Share by Type: 2020 VS 2026
Figure 2. Deep Brain Stimulation Features
Figure 3. Spinal Cord Stimulation Features
Figure 4. Transcranial Magnetic Stimulation Features
Figure 5. Global Neuromodulation Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Ambulatory Surgery Centers (ASCs) Case Studies
Figure 8. Neuromodulation Report Years Considered
Figure 9. Global Neuromodulation Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Neuromodulation Market Share by Regions: 2020 VS 2026
Figure 11. Global Neuromodulation Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Neuromodulation Market Share by Players in 2019
Figure 14. Global Top Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulation as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Neuromodulation Revenue in 2019
Figure 16. North America Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Neuromodulation Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
脳深部刺激療法（DBS）の世界市場（～2026年） Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the tre…- 外部神経調節の世界市場（～2026年） Market Analysis and Insights: Global External Neuromodulation Market The global External Neuromodulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global External Neuromodulation Scope and Market Size External Neuromodu…
- 内部神経調節の世界市場（～2026年） Market Analysis and Insights: Global Internal Neuromodulation Market The global Internal Neuromodulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 脊髄刺激システムの世界市場（～2026年） The spinal cord stimulation system is also known as a neurostimulation system which provides the therapeutic treatment of the chronic back, neck and extremity pain. The increasing prevalence of chronic and neuropathic pain disorders and the increasing technological advancements to the spinal cord st…
- 仙骨神経刺激の世界市場（～2026年） Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor. The external SNS device is one of the fastest growing product s…